198 related articles for article (PubMed ID: 9013966)
21. Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major.
Mbow ML; Bleyenberg JA; Hall LR; Titus RG
J Immunol; 1998 Nov; 161(10):5571-7. PubMed ID: 9820534
[TBL] [Abstract][Full Text] [Related]
22. Functional plasticity of the LACK-reactive Vbeta4-Valpha8 CD4(+) T cells normally producing the early IL-4 instructing Th2 cell development and susceptibility to Leishmania major in BALB / c mice.
Maillard I; Launois P; Himmelrich H; Acha-Orbea H; Diggelmann H; Locksley RM; Louis JA
Eur J Immunol; 2001 Apr; 31(4):1288-96. PubMed ID: 11298356
[TBL] [Abstract][Full Text] [Related]
23. Non-MHC-linked Th2 cell development induced by soluble protein administration predicts susceptibility to Leishmania major infection.
Guéry JC; Galbiati F; Smiroldo S; Adorini L
J Immunol; 1997 Sep; 159(5):2147-53. PubMed ID: 9278301
[TBL] [Abstract][Full Text] [Related]
24. Dissociation of disease susceptibility, inflammation and cytokine profile in lmr1/2 congenic mice infected with Leishmania major.
Elso C; Kumar B; Smyth G; Foote S; Handman E
Genes Immun; 2004 May; 5(3):188-96. PubMed ID: 14762398
[TBL] [Abstract][Full Text] [Related]
25. CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection.
Rosas LE; Barbi J; Lu B; Fujiwara Y; Gerard C; Sanders VM; Satoskar AR
Eur J Immunol; 2005 Feb; 35(2):515-23. PubMed ID: 15668916
[TBL] [Abstract][Full Text] [Related]
26. Effect of IL-7 treatment on Leishmania major-infected BALB.Xid mice: enhanced lymphopoiesis with sustained lack of B1 cells and clinical aggravation of disease.
Hoerauf A; Solbach W; Röllinghoff M; Gessner A
Int Immunol; 1995 Nov; 7(11):1879-84. PubMed ID: 8580086
[TBL] [Abstract][Full Text] [Related]
27. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major.
Doherty TM; Coffman RL
J Immunol; 1993 Jun; 150(12):5476-83. PubMed ID: 8515072
[TBL] [Abstract][Full Text] [Related]
28. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
29. Mice lacking NK cells develop an efficient Th1 response and control cutaneous Leishmania major infection.
Satoskar AR; Stamm LM; Zhang X; Satoskar AA; Okano M; Terhorst C; David JR; Wang B
J Immunol; 1999 Jun; 162(11):6747-54. PubMed ID: 10352294
[TBL] [Abstract][Full Text] [Related]
30. Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis.
Maekawa Y; Himeno K; Ishikawa H; Hisaeda H; Sakai T; Dainichi T; Asao T; Good RA; Katunuma N
J Immunol; 1998 Sep; 161(5):2120-7. PubMed ID: 9725203
[TBL] [Abstract][Full Text] [Related]
31. Splenectomy does not interfere with immune response to Leishmania major infection in mice.
Maioli TU; Carneiro CM; Assis FA; Faria AM
Cell Immunol; 2007 Sep; 249(1):1-7. PubMed ID: 18093575
[TBL] [Abstract][Full Text] [Related]
32. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR
Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
[TBL] [Abstract][Full Text] [Related]
33. Leishmania major-infected C3H mice treated with anti-IL-12 mAb develop but do not maintain a Th2 response.
Hondowicz BD; Scharton-Kersten TM; Jones DE; Scott P
J Immunol; 1997 Nov; 159(10):5024-31. PubMed ID: 9366430
[TBL] [Abstract][Full Text] [Related]
34. A role for gamma delta + T cells during experimental infection of mice with Leishmania major.
Rosat JP; MacDonald HR; Louis JA
J Immunol; 1993 Jan; 150(2):550-5. PubMed ID: 8419488
[TBL] [Abstract][Full Text] [Related]
35. Early parasite containment is decisive for resistance to Leishmania major infection.
Laskay T; Diefenbach A; Röllinghoff M; Solbach W
Eur J Immunol; 1995 Aug; 25(8):2220-7. PubMed ID: 7664785
[TBL] [Abstract][Full Text] [Related]
36. Coinfection with Listeria monocytogenes potentlxtes the response of BALB/c mice against Leishmania major.
Tabbara KS; Al-Azmi AS; Al Salem JA
J Egypt Soc Parasitol; 2004 Apr; 34(1):349-66. PubMed ID: 15125539
[TBL] [Abstract][Full Text] [Related]
37. Protective immunity against Leishmania major induced by Leishmania tropica infection of BALB/c mice.
Mahmoudzadeh-Niknam H; Kiaei SS; Iravani D
Exp Parasitol; 2011 Feb; 127(2):448-53. PubMed ID: 21035446
[TBL] [Abstract][Full Text] [Related]
38. Resistance of mice to experimental leishmaniasis is associated with more rapid appearance of mature macrophages in vitro and in vivo.
Sunderkötter C; Kunz M; Steinbrink K; Meinardus-Hager G; Goebeler M; Bildau H; Sorg C
J Immunol; 1993 Nov; 151(9):4891-901. PubMed ID: 8409447
[TBL] [Abstract][Full Text] [Related]
39. Targeted activation of CD8 cells and infection of beta 2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis.
Wang ZE; Reiner SL; Hatam F; Heinzel FP; Bouvier J; Turck CW; Locksley RM
J Immunol; 1993 Aug; 151(4):2077-86. PubMed ID: 8102158
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility to Leishmania major in IL-4 transgenic mice is not correlated with the lack of a Th1 immune response.
Erb KJ; Blank C; Moll H
Immunol Cell Biol; 1996 Jun; 74(3):239-44. PubMed ID: 8799723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
